Methyl 5-bromo-2-methylnicotinate

Catalog No. :
ACNBGP178
CAS No. :
1215916-40-7
Molecular Formula :
C8H8BrNO2
Molecular Weight :
230.06

IUPAC Name:methyl 5-bromo-2-methylnicotinate

Methyl 5-bromo-2-methylnicotinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$156.00Login to see priceIn stockIn stock
25g98%$775.00Login to see priceIn stockIn stock
100g98%$2174.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 5-bromo-2-methylnicotinate
IUPAC Namemethyl 5-bromo-2-methylnicotinate
MDL No.MFCD13705366
Molecular FormulaC8H8BrNO2
Molecular Weight230.06
SMILESO=C(OC)C1=C(C)N=CC(Br)=C1
InChI KeyUZSAODVBMBLKCX-UHFFFAOYSA-N
SynonymMethyl 5-bromo-2-methylnicotinate | 1215916-40-7 | methyl 5-bromo-2-methylpyridine-3-carboxylate | MFCD13705366 | 3-Pyridinecarboxylic acid, 5-bromo-2-methyl-, methyl ester | Methyl5-bromo-2-methylnicotinate | SCHEMBL20889335 | DTXSID70743770 | AMY10214 | AKOS016001949 | PB4
CAS No.1215916-40-7
PubChem CID70700991

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACNBGP178 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACOPMA741 route compound structure diagram
    ACOPMA741351003-02-6 In Stock
  4. Then
  5. ACNBGP178 route product structure diagram
    ACNBGP1781215916-40-7 In Stock
Inquiry

2. ACNBGP178 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOPMA741 route compound structure diagram
    ACOPMA741351003-02-6 In Stock
  4. Then
  5. ACNBGP178 route product structure diagram
    ACNBGP1781215916-40-7 In Stock
Inquiry

Comments (0)